Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)
NCT ID: NCT00543660
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
1998-03-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Staged and Combined Surgery for Cataract Patients With Corneal Endothelial Dysfunction
NCT02523950
Descemet Membrane Endothelial Keratoplasty Combined With Intraocular Lens Exchange: Sequential Versus Combined Surgery
NCT04344522
Predictive Factors of Good Results After Primary Descemet's Membrane Endothelial Keratoplasty (DMEK)
NCT04469933
Comparing Endoglide to Endoserter for DSAEK Graft Insertion
NCT01791075
DMEK And Cataract Surgery: Comparison Of Sequential Versus Combined Procedure
NCT03355924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm DSEK
Intervention: DSEK
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amnitrans Eyebank Rotterdam
OTHER
Melles CorneaClinic Rotterdam
UNKNOWN
Netherlands Institute for Innovative Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GRJ Melles, MD, PhD
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerrit RJ Melles, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Netherlands Institute for Innovative Ocular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Netherlands Institute for Innovative Ocular Surgery
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Melles GR. Posterior lamellar keratoplasty: DLEK to DSEK to DMEK. Cornea. 2006 Sep;25(8):879-81. doi: 10.1097/01.ico.0000243962.60392.4f. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIIOS.1998.04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.